Mike Klein
Mike Klein is CEO of Genomenon, Ann Arbor, Michigan, USA.
False
The Ultimate Vision for Rare Disease
February 28, 2022
Genomics and computational pathology can take rare disease diagnostics to the next level
1 min read
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
